LogicBio Therapeutics (LOGC) Misses Q4 EPS by 8c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts LOGC Hot Sheet
Price: $7.06 --0%
Financial Fact:
Loss per share (in dollars per share): -0.01
Today's EPS Names:
COHR, ATS, SICP, More
Financial Fact:
Loss per share (in dollars per share): -0.01
Today's EPS Names:
COHR, ATS, SICP, More
Join SI Premium – FREE
LogicBio Therapeutics (NASDAQ: LOGC) reported Q4 EPS of ($0.08).
For earnings history and earnings-related data on LogicBio Therapeutics (LOGC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CoreCivic (CXW) Misses Q3 EPS by 1530c; raises guidance
- Primerica (PRI) Tops Q3 EPS by 37c, Beats on Revenue
- Liberty Latin America (LILA) Reports Q3 results
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
